Comparing Ryzodeg 70/30 vs Tresiba
Ryzodeg 70/30 (insulin aspart/insulin degludec) | Tresiba (insulin degludec) |
|
---|
Ryzodeg 70/30 (insulin aspart/insulin degludec) | Tresiba (insulin degludec) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Type 2 Diabetes, Diabetes Mellitus, Diabetes - Type 1. Ryzodeg 70/30 may also be used for purposes not listed in this medication guide. |
Prescription only
Tresiba contains insulin degludec, an ultra-long-acting insulin that starts to work 60 minutes after administration and keeps working for up to 42 hours. Tresiba is approved for use in adults and... View more |
Related suggestions Type 2 Diabetes
Diabetes, Type 1
Diabetes Mellitus
|
|||||||
More about Ryzodeg 70/30 (insulin aspart/insulin degludec) | More about Tresiba (insulin degludec) | ||||||||
Ratings & Reviews | |||||||||
Ryzodeg 70/30 has an average rating of 4.5 out of 10 from a total of 4 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 25% reported a negative effect. |
Tresiba has an average rating of 4.4 out of 10 from a total of 153 ratings on Drugs.com. 29% of reviewers reported a positive effect, while 56% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Ryzodeg 70/30 side effects |
View all Tresiba side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
N/A |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Tresiba prices |
||||||||
Dosage Forms | |||||||||
N/A |
|
||||||||
Brand Names | |||||||||
N/A |
N/A |
||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
25 hours |
25 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 394 drugs are known to interact with Ryzodeg 70/30:
|
A total of 392 drugs are known to interact with Tresiba:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
N/A |
N/A |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
N/A |
|||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Rybelsus
Rybelsus tablets are used to improve blood sugar control in adults with type 2 diabetes, and may ...
Mounjaro
Mounjaro (tirzepatide) is FDA-approved to manage type 2 diabetes in adults. It lowers blood sugar ...
Trulicity
Trulicity is an injectable diabetes medicine that is used together with diet and exercise to ...
Lantus
Lantus is a long acting form of insulin used to treat type 1 or type 2 diabetes. Learn about side ...
Tresiba
Tresiba (insulin degludec) is used to treat diabetes mellitus. Includes Tresiba side effects ...
Victoza
Victoza helps control blood sugar levels and reduce the risk of serious heart problems in people ...
Basaglar
Basaglar (insulin glargine) is a long-acting insulin that is used to improve blood sugar control in ...
Humalog
Humalog (insulin lispro) is used to treat type 1 (insulin-dependent) diabetes in adults. Includes ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.